Edition:
United Kingdom

Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

41.00PLN
16 Aug 2019
Change (% chg)

0.00zł (+0.00%)
Prev Close
41.00zł
Open
41.50zł
Day's High
42.70zł
Day's Low
40.75zł
Volume
4,496
Avg. Vol
11,276
52-wk High
51.10zł
52-wk Low
28.25zł

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 27.09 0.144
FY 2018 Dec '18 35.14 0.139
Sep '18 31.70 0.184
Jun '18 30.24 0.169
Mar '18 28.17 0.168
FY 2017 Dec '17 25.91 0.139
Sep '17 24.21 0.109
Jun '17 28.61 0.187
Mar '17 28.39 0.112
 
*Note: Units in Millions ofPolish Zloty
**Note: Units in Polish Zloty

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-20 1 29.50 29.50 29.50 --
Sales and Profit Figures in Polish Złoty (PLN);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 73.54 29.73 33.85
P/E High - Last 5 Yrs. -- 47.56 54.29
P/E Low - Last 5 Yrs. -- 27.30 28.22
Beta -- 1.00 0.99
Price to Sales (TTM) 16.96 6.00 7.90
Price to Book (MRQ) 4.63 3.84 4.38
Price to Tangible Book (MRQ) 4.71 4.14 5.07
Price to Cash Flow (TTM) 44.04 21.62 23.70
% Owned Institutions -- 0.79 1.78

Dividends

  Company industry sector
Dividend Yield 0.36 1.83 1.67
Dividend Yield - 5 Year Avg -- 1.47 1.37
Dividend 5 Year Growth Rate -- 6.74 6.82
Payout Ratio(TTM) 37.71 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -3.82 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago 16.15 6.45 8.45
Sales - 5 Yr. Growth Rate -- 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago -14.03 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago 1.76 -- --
EPS - 5 Yr. Growth Rate -- 5.66 7.15
Capital Spending - 5 Yr. Growth Rate -- 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 6.95 2.52 2.52
Current Ratio (MRQ) 7.93 3.55 3.52
LT Debt to Equity (MRQ) 0.00 11.64 12.61
Total Debt to Equity (MRQ) 0.33 16.17 17.64
Interest Coverage (TTM) -- 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 65.27 51.41 50.25
Gross Margin - 5 Yr. Avg. -- 50.53 51.36
EBITD Margin (TTM) 43.01 -- --
EBITD - 5 Yr. Avg -- 17.64 16.42
Operating Margin (TTM) 27.56 -2.19 -6.97
Operating Margin - 5 Yr. Avg. -- 13.94 11.87
Pre-Tax Margin (TTM) 28.68 -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- 18.73 15.72
Net Profit Margin (TTM) 23.06 -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. -- 14.06 11.11
Effective Tax Rate (TTM) 19.59 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. -- 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 418,077 1,012,949,194 870,638,159
Net Income/Employee (TTM) 96,424 118,477,208 101,855,832
Receivable Turnover (TTM) 4.51 5.61 5.88
Inventory Turnover (TTM) 1.91 2.59 3.66
Asset Turnover (TTM) 0.22 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.10 10.57 10.25
Return on Assets - 5 Yr. Avg. -- 11.70 11.17
Return on Investment (TTM) 5.33 13.04 12.69
Return on Investment - 5 Yr. Avg. -- 14.80 14.15
Return on Equity (TTM) 6.35 14.12 17.13
Return on Equity - 5 Yr. Avg. -- 15.92 15.53
  1 Year 3 Year 5 Year
Sales % 16.92 -0.39 --
EPS (TTM) % 15.94 -18.95 --
Dividend % 41.18 -- --
Note: Units in Millions of US Dollars

Performance for Celon Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.13 9.21 99 47
13 Week 15.18 16.80 99 34
26 Week 50.79 52.08 99 15
52 Week 48.22 47.54 99 66
YTD 52.96 46.71 99 20
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.42%
# of Holders: 17
Total Shares Held: 11,891,056
3 Mo. Net Change: 380,469
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.